MARKET

VANI

VANI

Vivani Medical
NASDAQ
0.9846
-0.0254
-2.51%
Closed 16:00 03/24 EDT
OPEN
1.000
PREV CLOSE
1.010
HIGH
1.030
LOW
0.9500
VOLUME
23.02K
TURNOVER
13.33K
52 WEEK HIGH
8.10
52 WEEK LOW
0.8200
MARKET CAP
49.95M
P/E (TTM)
-3.6106
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 2d ago
BRIEF-Vivani Medical Announces Public Filing Of Registration Statement For The Proposed IPO Of Cortigent Inc
Reuters · 5d ago
Cortigent, developer of human vision restoration devices, files for $17M IPO
Seeking Alpha · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 12/29/2022 21:31
Vivani Medical Says Judgement Has Not Been Served On Co., Says May Appeal Decision Within 3 Months From Date Of Service
Benzinga · 12/15/2022 21:54
Vivani Medical Says On Dec. 9, 2022 Co. Received Notice That Paris Commercial Court Rendered Judgement, Finding Co.'s Termination Of MOU Was Not Valid
Benzinga · 12/15/2022 21:53
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 12/05/2022 17:31
ThinkEquity Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $7
Benzinga · 12/05/2022 14:16
More
About VANI
Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The Company is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The Company's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The Company's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.

Webull offers kinds of Vivani Medical Inc stock information, including NASDAQ:VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.